Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A N Frix

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Revue Medicale De Liege|November 19, 2020
[COVID-19 and asthma]R Louis, D Calmes, A N Frix, et al.
Biochemical Pharmacology|April 3, 2020
Effectiveness of omalizumab on patient reported outcomes, lung function, and inflammatory markers in severe allergic asthmaA N Frix, F Schleich, V Paulus, et al.
Revue Medicale De Liege|June 5, 2020
[Asthma : the contribution of biotherapies]F Schleich, A N Frix, V Paulus, et al.
Scientific Reports|January 29, 2026
Author Correction: Forced oscillation technique in progressive pulmonary fibrosis in a single-center retrospective studyA Denis, M Henket, L Giltay, et al.
Scientific Reports|May 2, 2025
Forced oscillation technique in progressive pulmonary fibrosis in a single-center retrospective studyA Denis, M Henket, L Giltay, et al.
Respiratory Research|November 25, 2020
Could KL-6 levels in COVID-19 help to predict lung disease?A N Frix, L Schoneveld, A Ladang, et al.
Respiratory Investigation|September 26, 2020
Single-center experience of patients with interstitial lung diseases during the early days of the COVID-19 pandemicJ Guiot, M Henket, A N Frix, et al.
Revue Medicale De Liege|June 3, 2022
[Asthma in clinical practice: from inflammatory phenotypes to personalized treatment]F Schleich, S Graff, N Bougard, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Revue Medicale De Liege|November 19, 2020
[COVID-19 and asthma]R Louis, D Calmes, A N Frix, et al.
Biochemical Pharmacology|April 3, 2020
Effectiveness of omalizumab on patient reported outcomes, lung function, and inflammatory markers in severe allergic asthmaA N Frix, F Schleich, V Paulus, et al.
Revue Medicale De Liege|June 5, 2020
[Asthma : the contribution of biotherapies]F Schleich, A N Frix, V Paulus, et al.
Scientific Reports|January 29, 2026
Author Correction: Forced oscillation technique in progressive pulmonary fibrosis in a single-center retrospective studyA Denis, M Henket, L Giltay, et al.
Scientific Reports|May 2, 2025
Forced oscillation technique in progressive pulmonary fibrosis in a single-center retrospective studyA Denis, M Henket, L Giltay, et al.
Respiratory Research|November 25, 2020
Could KL-6 levels in COVID-19 help to predict lung disease?A N Frix, L Schoneveld, A Ladang, et al.
Respiratory Investigation|September 26, 2020
Single-center experience of patients with interstitial lung diseases during the early days of the COVID-19 pandemicJ Guiot, M Henket, A N Frix, et al.
Revue Medicale De Liege|June 3, 2022
[Asthma in clinical practice: from inflammatory phenotypes to personalized treatment]F Schleich, S Graff, N Bougard, et al.
Pageof 1